Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
50 participants
OBSERVATIONAL
2019-02-01
2020-01-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The chromosomal status of the embryo from an embryo biopsy of trophoectoderm will be established (usual clinical practice), the chromosomal endowment from the DNA of the embryonic culture medium will be determined, and the results using the NICS and the conventional invasive method (Preimplantation Genetic Testing for Aneuploidy \[PGT-A\]) will be compared.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Embryo Selection by Noninvasive Preimplantation Genetic Test
NCT04339166
Correlation of the Genetic Constitution of the Spent Blastocyst Media
NCT06780605
Selection of the Embryo to Transfer by Morphokinetics vs. Morphological Evaluation.
NCT04003337
Chromosomal Analysis of Single Cells in Human Embryos
NCT00614367
Investigating the Cryopreserved Blastocyst's ImplantatiOn Potential After Genetic Screening
NCT03173885
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Study group
No intervention. Couples who come to the study center to carry out a PGT-A cycle will be selected. Only couples that will use their own gametes will be selected and the indication of PGT-A will be advanced maternal age, failure of implantation, repeat abortion, male factor or structural chromosomal alterations. The results of chromosomal status of the embryo will be compared using the NICS and the conventional invasive method (PGT-A).
Noninvasive chromosome screening
Screening based on MALBAC-NGS technology
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Noninvasive chromosome screening
Screening based on MALBAC-NGS technology
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Embryonic cryopreservation.
* Informed consent signature
Exclusion Criteria
* Embryonic block.
* Bad embryo quality.
19 Years
49 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Instituto Bernabeu
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Belen Lledo
Principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Belén Lledo, PhD
Role: PRINCIPAL_INVESTIGATOR
Instituto Bernabeu
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Instituto Bernabeu
Alicante, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IBB11
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.